Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin.
Di Franco S, Parrino B, Gaggianesi M, Pantina VD, Bianca P, Nicotra A, Mangiapane LR, Lo Iacono M, Ganduscio G, Veschi V, Brancato OR, Glaviano A, Turdo A, Pillitteri I, Colarossi L, Cascioferro S, Carbone D, Pecoraro C, Fiori ME, De Maria R, Todaro M, Screpanti I, Cirrincione G, Diana P, Stassi G. Di Franco S, et al. Among authors: ganduscio g. iScience. 2021 May 29;24(6):102664. doi: 10.1016/j.isci.2021.102664. eCollection 2021 Jun 25. iScience. 2021. PMID: 34169240 Free PMC article.
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G. Mangiapane LR, et al. Among authors: ganduscio g. Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. Gut. 2022. PMID: 33436496 Free PMC article.
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy.
Turdo A, Glaviano A, Pepe G, Calapà F, Raimondo S, Fiori ME, Carbone D, Basilicata MG, Di Sarno V, Ostacolo C, Parrino B, Cascioferro S, Pecoraro C, Di Franco S, Bellavia D, Gaggianesi M, Veschi V, Lo Iacono M, Ganduscio G, Pantina VD, Mangiapane LR, Bongiorno MR, Alessandro R, Todaro M, De Maria R, Diana P, Campiglia P, Stassi G. Turdo A, et al. Among authors: ganduscio g. Cancers (Basel). 2021 Aug 4;13(16):3927. doi: 10.3390/cancers13163927. Cancers (Basel). 2021. PMID: 34439086 Free PMC article.
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study.
Alongi P, Laudicella R, Stefano A, Caobelli F, Comelli A, Vento A, Sardina D, Ganduscio G, Toia P, Ceci F, Mapelli P, Picchio M, Midiri M, Baldari S, Lagalla R, Russo G. Alongi P, et al. Among authors: ganduscio g. Q J Nucl Med Mol Imaging. 2022 Dec;66(4):352-360. doi: 10.23736/S1824-4785.20.03227-6. Epub 2020 Jun 15. Q J Nucl Med Mol Imaging. 2022. PMID: 32543166
18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis.
Laudicella R, Albano D, Alongi P, Argiroffi G, Bauckneht M, Baldari S, Bertagna F, Boero M, Vincentis G, Sole AD, Rubini G, Fantechi L, Frantellizzi V, Ganduscio G, Guglielmo P, Nappi AG, Evangelista L; on the behalf of Young AIMN Working Group. Laudicella R, et al. Among authors: ganduscio g. Cancers (Basel). 2019 Sep 11;11(9):1348. doi: 10.3390/cancers11091348. Cancers (Basel). 2019. PMID: 31514479 Free PMC article. Review.
Potential clinical value of quantitative fluorine-18-fluorodeoxyglucose-PET/computed tomography using a graph-based method analysis in evaluation of incidental lesions of gastrointestinal tract: correlation with endoscopic and histopathological findings.
Alongi P, Laudicella R, Gentile R, Scalisi S, Stefano A, Russo G, Grassedonio E, Albano D, Pompei G, Rossi F, Raimondo D, Ganduscio G, Midiri M, Sinagra E. Alongi P, et al. Among authors: ganduscio g. Nucl Med Commun. 2019 Oct;40(10):1060-1065. doi: 10.1097/MNM.0000000000001062. Nucl Med Commun. 2019. PMID: 31365492